NEW YORK (GenomeWeb News) – Response Genetics today announced it has reached a contract with preferred provider organization Three Rivers Provider Network.
As a result, the more than 10 million members in Three Rivers will have access to Response's predictive genomic tests, which provides insight into a patient's tumor and potentially effective therapies.
Financial and other terms of the deal were not disclosed.
Three Rivers comprises more than 600,000 total providers, including more than 5,000 hospitals and 70,000 ancillary facilities.
The deal with Three Rivers is Response's fourth with a payor in recent months, following agreements with Blue Shield of California, Blue Cross Blue Shield of Illinois, and MultiPlan.
Last month, the Los Angeles-based firm said it bought Pathwork Diagnostics' assets, and last week, it announced it had signed definitive agreements with investors to raise $1.9 million.